Mangoceuticals(MGRX.US) Director Sells US$39,834.26 in Common Stock

$Mangoceuticals(MGRX.US)$ Director Hamilton Alex P. sold 125K shares of common stock on Jun 25, 26, 2024 at an average price of $0.32 for a total value of $39,834.26.Source: Announcement What is state

Moomoo NewsJun 27 19:06 ET

Mangoceuticals Patent Approved for Preventive Care in Australia

Mangoceuticals (MGRX) said Thursday it obtained a notice of acceptance from the Australian government for its patent application for its technology designed to prevent orally acquired illnesses. The p

MT NewswiresJun 6 14:17 ET

Express News | Mangorx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

ReutersJun 6 08:32 ET

Express News | MangoRx Receives Notice of Acceptance For Australian Patent Application No. 2020235666

BenzingaJun 6 08:31 ET

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products

GlobeNewswireJun 6 08:30 ET

Mangoceuticals Stock Rallies on Japanese Patent Allowance

Seeking AlphaJun 4 16:52 ET